查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
经皮贴片的全球市场：按类型、黏合剂、应用、配销通路和最终用户 - 预测（至 2029 年）
市场调查报告书
商品编码
1393004

经皮贴片的全球市场：按类型、黏合剂、应用、配销通路和最终用户 - 预测（至 2029 年）

Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End User - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 282 Pages | 订单完成后即时交付

价格
简介目录

报告概述

调查范围
调查年份 2021-2029
基准年 2022年
预测期 2023-2029
单元 10亿美元
部分 贴片类型、黏合剂类型、应用、配销通路、最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

全球经皮贴片市场规模预计到2023年将达到62亿美元，到2029年将达到80亿美元，2023年至2029年年复合成长率为4.5%。

市场成长驱动因素包括慢性病的流行、止痛贴片的使用增加、经皮贴片技术的进步以及从传统注射剂转向经皮贴片的转变。然而，药物缺陷、经皮给药系统召回以及医疗设施成本增加等因素预计将在预测期内一定程度上抑制市场扩张。

“根据补丁类型，矩阵补丁部分预计将以最高的年复合成长率增长。”

由于具有增强贴片吸引力和有效性的许多功能，矩阵贴片细分市场预计将以最高的年复合成长率成长。基质贴片配方和製造方面的持续技术改进提高了患者的依从性和基质贴片的功效。

“就粘合剂而言，有机硅粘合剂领域预计将以最高的年复合成长率增长。”

由于有机硅黏合剂与其他黏合剂相比具有特殊优势，有机硅黏合剂贴片领域预计将以市场上最高的年复合成长率成长。

“从应用来看，疼痛管理领域预计将以市场上最高的年复合成长率增长。”

由于对安全和非侵入性疼痛缓解方案的需求不断增加，因此预期疼痛管理领域的市场成长率最高。经皮止痛贴片透过有针对性、受控的方式透过皮肤输送止痛药物，从而提供均匀、稳定的治疗效果。这种方法提供了侵入性治疗和传统口服药物的替代方案，使其对患有慢性疼痛疾病的人特别有吸引力。

“从配销通路来看，线上药房领域预计将以市场上最高的年复合成长率增长。”

这是由于整体数位化趋势以及医疗产品对电子商务平台的依赖程度增加。透过线上药局，顾客可以在家中舒适地轻鬆便捷地获得经皮贴片。电子商务的日益普及及其便利的订购和宅配能力正在满足患者不断变化的无忧医疗保健需求。

“对于最终用户来说，居家照护环境领域预计将以市场上最高的年复合成长率增长。”

由于以患者为中心的个人化医疗趋势不断增长，居家照护环境领域预计将作为最终用户成长最快。经皮贴片提供了一种方便、非侵入性的给药方法，使其特别适合在家中自我给药。高龄化和慢性病的增加增加了对可获得的长期替代治疗的需求。经皮贴片非常适合这种新的医学范例。

“在预测期内，亚太地区将以市场中最高的年复合成长率增长。”

由于各种因素突显该地区医疗保健形势的变化，预计亚太市场将以最高的年复合成长率成长。由于慢性病盛行率的上升以及对非侵入性药物输送技术的了解不断增长，经皮贴片变得越来越普及。该地区人口众多和人口高龄化是医疗保健成本上升的关键驱动因素，导致对方便且患者友善的治疗方案的需求增加。由于药品研发的突破、可支配所得的增加和医疗基础设施的改善，亚太市场也有望扩大。

本报告研究和分析了全球经皮贴片市场，提供了关键驱动因素和抑制因素、竞争形势和未来趋势的资讯。

目录

第1章简介

第2章调查方法

第3章执行摘要

第4章重要考察

  • 经皮贴片市场概况
  • 亚太地区经皮贴片市场：依贴片类型、国家分类（2022 年）
  • 经皮贴片市场：地理成长机会
  • 经皮贴片市场：依地区、成分分类（2021-2029）
  • 经皮贴片市场：开发中国家国家市场 VS 已开发国家市场

第5章市场概况

  • 介绍
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 技术分析
  • 产业动态
  • 价值链分析
  • 供应链分析
  • 贸易分析
  • 波特五力分析
  • 关税和监管形势
    • 监管分析
    • 监管机构、政府机构和其他组织
  • 专利分析
  • 价格分析
  • 主要会议和活动（2023-2024）
  • 主要利害关係人和采购标准
  • 生态系/市场地图
  • 邻近市场分析
  • 影响客户业务的趋势/干扰
  • 未满足的需求

第6章透皮贴片市场：依贴片类型

  • 介绍
  • 带药物的黏合贴片
    • 单层药物填充贴剂
    • 多层药物填充贴剂
  • 矩阵补丁
  • 储库膜贴片
  • 微针贴片
  • 离子电渗透疗法贴片
  • 蒸气贴片

第7章透皮贴片市场：依黏合剂类型

  • 介绍
  • 丙烯酸黏合剂
  • 硅胶黏合剂
  • 水凝胶黏合剂
  • 其他黏合剂

第8章贴片市场：依应用分类

  • 介绍
  • 疼痛管理
  • 禁止抽烟
  • 荷尔蒙替代疗法
    • 经皮睪酮疗法
    • 经皮雌激素疗法
  • 中枢神经系统疾病
  • 心血管疾病
  • 其他用途

第9章贴片市场：依配销通路

  • 介绍
  • 医院药房
  • 零售药房
  • 线上药房

第10章贴片市场：依最终用户分类

  • 介绍
  • 居家照护环境
  • 医院/诊所

第11章贴片市场：按地区

  • 介绍
  • 北美洲
    • 景气衰退对北美经皮贴片市场的影响
    • 美国
    • 加拿大
  • 欧洲
    • 景气衰退对欧洲经皮贴片市场的影响
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 景气衰退对亚太经皮贴片市场的影响
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 拉丁美洲
    • 景气衰退对拉丁美洲经皮贴片市场的影响
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东/非洲

第12章竞争形势

  • 介绍
  • 主要市场公司收益分析
  • 市场占有率分析
  • 企业足迹
  • 经皮贴片市场：研发支出
  • 公司评级矩阵
  • 中小企业/新创企业评估矩阵
  • 竞争现状及趋势

第13章公司简介

  • 主要企业
    • HISAMITSU PHARMACEUTICAL CO., INC.
    • VIATRIS INC.
    • NOVARTIS AG
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • JOHNSON & JOHNSON
    • UCB SA
    • ENDO INTERNATIONAL PLC
    • LUYE PHARMA GROUP
    • ABBVIE INC.
    • NITTO DENKO CORPORATION
    • CIPLA INC.
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • AGILE THERAPEUTICS
    • BAYER AG
    • AMNEAL PHARMACEUTICALS LLC
    • HIKMA PHARMACEUTICALS PLC
  • 其他公司
    • ALVOGEN GROUP INC.
    • SPARSHA PHARMA INTERNATIONAL PVT. LTD.
    • IONTOPATCH
    • MEDHERANT LIMITED
    • ADHEXPHARMA
    • EVERNOW
    • LEAD CHEMICAL CO., LTD.
    • PURDUE PHARMA LP
    • MUNDIPHARMA INTERNATIONAL
  • COMPANIES PROVIDING ADHESIVES FOR TRANSDERMAL PATCHES
    • WACKER CHEMIE AG
    • ELKEM ASA
    • DUPONT DE NEMOURS, INC.
    • KATECHO, LLC
    • POLYMER SCIENCE, INC.

第14章附录

简介目录
Product Code: MD 8869

Report Description

Scope of the Report
Years Considered for the Study2021-2029
Base Year2022
Forecast Period2023-2029
Units ConsideredValue (USD) Billion
SegmentsPatch Type, Adhesive Type, Application, Distribution Channel, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The global transdermal patches market is projected to reach 8.0 USD Billion by 2029 from USD 6.2 Billion in 2023, at a CAGR of 4.5% from 2023 to 2029. The factors driving the growth of the global transdermal patches market include the rising prevalence of chronic diseases, the expanding use of analgesic patches, technological advancements in transdermal patches, and the shift from traditional injections to transdermal patches. Nonetheless, during the anticipated period, factors such as drug failures, recalls of transdermal drug delivery systems, and increasing healthcare facility expenses will probably constrain market expansion to some degree.

"The matrix patches segment is expected to grow with the highest CAGR in patch type of the transdermal patches market."

Due to a number of characteristics that increase the patch's appeal and efficacy, the matrix patches segment is expected to grow at the highest CAGR in the transdermal patch market. In matrix patches, the medicine is evenly dispersed within a polymer matrix, providing a straightforward but effective design. This design promotes the best possible drug absorption via the skin by enabling a prolonged, regulated release of the medicinal substance. Due to its adaptability, matrix patches are widely used in a variety of therapeutic fields. This is because they may be used to administer a broad range of drugs. Patient compliance and matrix patch efficacy are increasing as a result of ongoing technological improvements in matrix patch formulation and manufacturing.

"The silicone adhesives segment is expected to grow with the highest CAGR in the adhesive type of the transdermal patches market."

Since silicone adhesives have particular advantages over other adhesives, it is expected that the silicone adhesive patches segment of the transdermal patch market will grow at the fastest CAGR. Silicone adhesives ensure patient comfort and adherence by forming a thin yet strong connection with the skin. Because they are biocompatible and hypoallergenic, they can be used by a wide range of patients with less chance of skin sensitivity or irritation. Silicone adhesive patches' conformability and flexibility make them more comfortable to wear and encourage prolonged and regular use.

"Based on the Application Type, the pain management segment is expected to grow by the highest CAGR in the transdermal patches market."

The market for transdermal patches is expected to grow at the fastest rate in the pain management segment due to the growing need for safe, non-invasive pain reduction options. Pain-relieving transdermal patches deliver an even and steady therapeutic impact by releasing analgesic drugs through the skin in a targeted and regulated manner. This method offers an alternative to invasive therapies and conventional oral drugs, making it especially tempting to people with chronic pain disorders.

"Based on the Distribution Channel, The online Pharmacies segment is expected to grow with the highest CAGR in the transdermal patches market."

As a distribution channel for transdermal patches, the online pharmacies segment is anticipated to grow at the fastest rate in the market. This is due to the general trend of digitalization and the growing dependence of healthcare items on e-commerce platforms. Customers can get transdermal patches easily and conveniently from the comfort of their homes with the help of online pharmacies. The increasing popularity of e-commerce, together with its convenient ordering and doorstep delivery features, corresponds with the changing needs of patients who want hassle-free access to healthcare.

"Based on the End User, The Homecare Settings segment is expected to grow with the highest CAGR in the transdermal patches market."

Given the growing trend towards patient-centered and personalized healthcare, the transdermal patch market's homecare settings sector is expected to grow at the fastest rate as an end-user. For self-administration in domestic settings, transdermal patches are especially well-suited since they offer a convenient and non-invasive way to administer medication. The need for accessible, long-term treatment alternatives is fueled by the aging population and the rise of chronic illnesses. Transdermal patches are a perfect fit with this new paradigm in healthcare since homecare settings provide people the freedom to take care of their healthcare needs on their own.

"Asia Pacific to grow with the highest CAGR in the transdermal patches market during the forecast period."

The transdermal patch market in Asia Pacific is expected to grow at the highest CAGR due to an array of factors that highlight the region's changing healthcare landscape. Transdermal patches are becoming more and more popular due to the rising incidence of chronic illnesses and rising knowledge of non-invasive medication delivery techniques. The huge and aging population in the area is a major factor in the rising cost of healthcare, which in turn is driving up demand for accessible and patient-friendly treatment choices. The transdermal patch market in Asia Pacific is also expected to rise as a result of breakthroughs in pharmaceutical research and development, rising disposable incomes, and improved healthcare infrastructure.

A breakdown of the primary participants (supply-side) for the transdermal patches market referred to for this report is provided below:

  • By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3-25%
  • By Designation: C-level-42%, Director Level-29%, and Others-29%
  • By Region: North America-30%, Europe-25%, Asia Pacific-30%, Latin America- 10%, Middle East & Africa-5%

The prominent players in the transdermal patches market include Johnson & Johnson (U.S.), Viatris Inc. (U.S.), Hisamatsu Pharmaceuticals Co. Ltd. (Japan), Cipla Inc. (India), Teva Pharmaceutical Industries Ltd. (Israel), Agile Therapeutics (U.S.), Bayer AG (Germany), Luye Pharma Group (China), Sparsha Pharma International Pvt Ltd (India), Iontopatch (U.S.), Medherant Limited (U.K.), AdhexPharma (France), Evernow (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Alvogen Group Inc. (U.S.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Nitto Denko Corporation (Japan), USB S.A. (Belgium), Boehringer Ingelheim International GmbH (Germany), Endo International plc. (Ireland), LEAD CHEMICAL Co., Ltd. (Japan), Purdue Pharma L.P (U.S.) and Mundipharma International (U.K.).

Research Coverage:

The market study covers the transdermal patches market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by patch type, adhesive type, application, distribution type, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall transdermal patches market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (Increasing prevalence of chronic diseases, Growing adoption of analgesic patches, Technological advancements in transdermal patches, Switching from conventional needle injections to transdermal patches), restraints (High procedural cost of vascular surgeries and associated products, Drug failure and recalls of transdermal drug delivery systems, Rising cost of healthcare facilities), opportunities (Collaborations between pharmaceutical companies and drug delivery firms, Self-administration and home care drug delivery systems) and challenges (Technical barriers related to skin irritation and permeability, Lack of skilled professionals)
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global transdermal patches market. The report analyzes this market by patch type, adhesive type, application, distribution channel, end-user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global transdermal patches market.
  • Market Development: Comprehensive information on the lucrative emerging markets by patch type, adhesive type, application, distribution channel, end-user, and region.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global transdermal patches market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global transdermal patches market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 INCLUSIONS AND EXCLUSIONS OF STUDY
    • 1.3.2 MARKETS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 STAKEHOLDERS
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: JOHNSON & JOHNSON
    • FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: TRANSDERMAL PATCHES MARKET (2022)
    • FIGURE 9 BOTTOM-UP APPROACH
    • FIGURE 10 TOP-DOWN APPROACH
    • FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2029)
    • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR STUDY
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 SCOPE-RELATED LIMITATIONS
    • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: TRANSDERMAL PATCHES MARKET
  • 2.8 IMPACT OF RECESSION ON TRANSDERMAL PATCHES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 14 TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2023 VS. 2029 (USD MILLION)
    • FIGURE 15 TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2023 VS. 2029 (USD MILLION)
    • FIGURE 16 TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
    • FIGURE 17 TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2029 (USD MILLION)
    • FIGURE 18 TRANSDERMAL PATCHES MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
    • FIGURE 19 GEOGRAPHICAL SNAPSHOT OF TRANSDERMAL PATCHES MARKET

4 PREMIUM INSIGHTS

  • 4.1 TRANSDERMAL PATCHES MARKET OVERVIEW
    • FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE AND COUNTRY (2022)
    • FIGURE 21 DRUG-IN-ADHESIVE PATCHES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 TRANSDERMAL PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 TRANSDERMAL PATCHES MARKET, REGIONAL MIX, 2021-2029
    • FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE TRANSDERMAL PATCHES MARKET DURING FORECAST PERIOD
  • 4.5 TRANSDERMAL PATCHES MARKET: DEVELOPING VS. DEVELOPED MARKETS
    • FIGURE 24 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 25 TRANSDERMAL PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of chronic diseases
      • 5.2.1.2 Growing adoption of analgesic patches
      • 5.2.1.3 Technological advancements in transdermal patches
      • 5.2.1.4 Switching from conventional needle injections to transdermal patches
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High procedural cost of transdermal surgeries and associated products
      • 5.2.2.2 Drug failure and recalls of transdermal drug delivery systems
      • 5.2.2.3 Rising cost of healthcare facilities
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Collaborations between pharmaceutical companies and drug delivery firms
      • 5.2.3.2 Self-administration and home care drug delivery systems
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Technical barriers related to skin irritation and permeability
      • 5.2.4.2 Lack of skilled professionals
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 ADVANCEMENTS IN TRANSDERMAL DRUG DELIVERY SYSTEMS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 26 TRANSDERMAL PATCHES MARKET: VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 27 TRANSDERMAL PATCHES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR TRANSDERMAL PATCHES
    • TABLE 3 IMPORT AND EXPORT DATA FOR TRANSDERMAL PATCHES, BY COUNTRY, 2022
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 TRANSDERMAL PATCHES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 TARIFF AND REGULATORY LANDSCAPE
    • 5.9.1 REGULATORY ANALYSIS
      • 5.9.1.1 North America
        • 5.9.1.1.1 US
        • 5.9.1.1.2 Canada
      • 5.9.1.2 Europe
      • 5.9.1.3 Asia Pacific
        • 5.9.1.3.1 China
        • 5.9.1.3.2 Japan
        • 5.9.1.3.3 India
      • 5.9.1.4 Latin America
        • 5.9.1.4.1 Brazil
        • 5.9.1.4.2 Mexico
      • 5.9.1.5 Middle East
      • 5.9.1.6 Africa
    • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PATENT ANALYSIS
    • 5.10.1 PATENT PUBLICATION TRENDS FOR TRANSDERMAL PATCHES
    • FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2015-DECEMBER 2022)
    • 5.10.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN TRANSDERMAL PATCHES MARKET
    • FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR TRANSDERMAL PATCH PATENTS (JANUARY 2015-DECEMBER 2022)
    • FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR TRANSDERMAL PATCHES (JANUARY 2015-APRIL 2022)
  • 5.11 PRICING ANALYSIS
    • TABLE 10 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY APPLICATION
    • TABLE 11 REGIONAL PRICING ANALYSIS OF TRANSDERMAL PATCHES, 2023 (USD)
  • 5.12 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 12 TRANSDERMAL PATCHES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSDERMAL PATCHES
    • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSDERMAL PATCHES
    • 5.13.2 BUYING CRITERIA
    • FIGURE 32 KEY BUYING CRITERIA FOR TRANSDERMAL PATCHES
    • TABLE 14 KEY BUYING CRITERIA FOR TRANSDERMAL PATCHES
  • 5.14 ECOSYSTEM/MARKET MAP
    • FIGURE 33 TRANSDERMAL PATCHES MARKET: ECOSYSTEM/MARKET MAP
  • 5.15 ADJACENT MARKET ANALYSIS
    • FIGURE 34 TRANSDERMAL PATCHES MARKET: ADJACENT MARKETS
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.17 UNMET NEEDS

6 TRANSDERMAL PATCHES MARKET, BY PATCH TYPE

  • 6.1 INTRODUCTION
    • TABLE 15 TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
  • 6.2 DRUG-IN-ADHESIVE PATCHES
    • TABLE 16 DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 17 DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 6.2.1 SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES
      • 6.2.1.1 Used to deliver wide range of medications
    • TABLE 18 SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 6.2.2 MULTI-LAYER DRUG-IN-ADHESIVE PATCHES
      • 6.2.2.1 Enhanced drug release and reduced side effects to drive adoption
    • TABLE 19 MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.3 MATRIX PATCHES
    • 6.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEW MATRIX MATERIALS TO SUPPORT MARKET GROWTH
    • TABLE 20 MATRIX TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.4 RESERVOIR MEMBRANE PATCHES
    • 6.4.1 OFFER GREAT CONTROL OVER DRUG DELIVERY RATES
    • TABLE 21 RESERVOIR MEMBRANE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.5 MICRONEEDLE PATCHES
    • 6.5.1 ABILITY TO DELIVER ACTIVE PHARMACEUTICAL INGREDIENTS TO BOOST ADOPTION
    • TABLE 22 MICRONEEDLE TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.6 IONTOPHORESIS PATCHES
    • 6.6.1 USED TO DELIVER MEDICINES WITH LOW MOLECULAR WEIGHT
    • TABLE 23 IONTOPHORESIS TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 6.7 VAPOR PATCHES
    • 6.7.1 RELEASE ESSENTIAL OILS FOR UP TO 6 HOURS
    • TABLE 24 VAPOR TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)

7 TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE

  • 7.1 INTRODUCTION
    • TABLE 25 TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
  • 7.2 ACRYLIC ADHESIVES
    • 7.2.1 HIGH DURABILITY TO BOOST DEMAND
    • TABLE 26 TRANSDERMAL PATCHES MARKET FOR ACRYLIC ADHESIVES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.3 SILICONE ADHESIVES
    • 7.3.1 LOW PEEL ADHESION PROPERTY MAKES IT IDEAL FOR MEDICAL APPLICATIONS
    • TABLE 27 TRANSDERMAL PATCHES MARKET FOR SILICONE ADHESIVES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.4 HYDROGEL ADHESIVES
    • 7.4.1 INCREASING DEMAND FOR TRANSDERMAL DRUG DELIVERY SYSTEMS TO DRIVE MARKET
    • TABLE 28 TRANSDERMAL PATCHES MARKET FOR HYDROGEL ADHESIVES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.5 OTHER ADHESIVES
    • TABLE 29 TRANSDERMAL PATCHES MARKET FOR OTHER ADHESIVES, BY COUNTRY, 2021-2029 (USD MILLION)

8 TRANSDERMAL PATCHES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 30 TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • 8.2 PAIN MANAGEMENT
    • 8.2.1 HIGH BURDEN OF CHRONIC PAIN WORLDWIDE TO DRIVE MARKET
    • TABLE 31 TRANSDERMAL PATCHES AVAILABLE FOR PAIN MANAGEMENT
    • TABLE 32 TRANSDERMAL PATCHES MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3 SMOKING CESSATION
    • 8.3.1 CONTROLLED DRUG DELIVERY AND REDUCED SIDE EFFECTS TO SUPPORT MARKET GROWTH
    • TABLE 33 TRANSDERMAL PATCHES AVAILABLE FOR SMOKING CESSATION
    • TABLE 34 TRANSDERMAL PATCHES MARKET FOR SMOKING CESSATION, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.4 HORMONE REPLACEMENT THERAPY
    • TABLE 35 TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 36 TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.4.1 TRANSDERMAL TESTOSTERONE THERAPY
      • 8.4.1.1 Increased bone density, better muscle development, and reduced risk factors to support market growth
    • TABLE 37 TRANSDERMAL PATCHES AVAILABLE FOR TRANSDERMAL TESTOSTERONE THERAPY
    • TABLE 38 TRANSDERMAL PATCHES MARKET FOR TRANSDERMAL TESTOSTERONE THERAPY, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.4.2 TRANSDERMAL ESTROGEN THERAPY
      • 8.4.2.1 Growing use of transdermal contraceptive patches to drive market
    • TABLE 39 TRANSDERMAL PATCHES AVAILABLE FOR TRANSDERMAL ESTROGEN THERAPY
    • TABLE 40 TRANSDERMAL PATCHES MARKET FOR TRANSDERMAL ESTROGEN THERAPY, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.5 CENTRAL NERVOUS SYSTEM DISORDERS
    • 8.5.1 EASE OF USE, SIMPLE TREATMENT REGIMEN, AND CONTINUOUS DELIVERY OF DRUGS TO DRIVE ADOPTION
    • TABLE 41 TRANSDERMAL PATCHES AVAILABLE FOR CENTRAL NERVOUS SYSTEM DISORDERS
    • TABLE 42 TRANSDERMAL PATCHES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.6 CARDIOVASCULAR DISEASES
    • 8.6.1 AVAILABILITY OF ALTERNATIVE AND ADVANCED DRUG DELIVERY OPTIONS TO LIMIT MARKET GROWTH
    • TABLE 43 TRANSDERMAL PATCHES AVAILABLE FOR CARDIOVASCULAR DISEASES
    • TABLE 44 TRANSDERMAL PATCHES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.7 OTHER APPLICATIONS
    • TABLE 45 TRANSDERMAL PATCHES AVAILABLE FOR OTHER APPLICATIONS
    • TABLE 46 TRANSDERMAL PATCHES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)

9 TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 INTRODUCTION
    • TABLE 47 TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • 9.2 HOSPITAL PHARMACIES
    • 9.2.1 LARGEST DISTRIBUTION CHANNEL FOR TRANSDERMAL PATCHES
    • TABLE 48 TRANSDERMAL PATCHES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 9.3 RETAIL PHARMACIES
    • 9.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    • TABLE 49 TRANSDERMAL PATCHES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 9.4 ONLINE PHARMACIES
    • 9.4.1 FASTEST-GROWING SEGMENT DUE TO EASY ACCESSIBILITY TO MEDICATIONS
    • TABLE 50 TRANSDERMAL PATCHES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021-2029 (USD MILLION)

10 TRANSDERMAL PATCHES MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 51 TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 10.2 HOME CARE SETTINGS
    • 10.2.1 RAPID GROWTH IN GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
    • TABLE 52 TRANSDERMAL PATCHES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 10.3 HOSPITALS & CLINICS
    • 10.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
    • TABLE 53 TRANSDERMAL PATCHES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2029 (USD MILLION)

11 TRANSDERMAL PATCHES MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 54 TRANSDERMAL PATCHES MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 IMPACT OF RECESSION ON NORTH AMERICAN TRANSDERMAL PATCHES MARKET
    • FIGURE 36 NORTH AMERICA: TRANSDERMAL PATCHES MARKET SNAPSHOT
    • TABLE 55 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 56 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 57 NORTH AMERICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 58 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 59 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 60 NORTH AMERICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 61 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 62 NORTH AMERICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 Largest market for transdermal patches
    • TABLE 63 US: MACROECONOMIC INDICATORS
    • TABLE 64 US: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 65 US: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 66 US: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 67 US: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 68 US: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 69 US: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 70 US: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Rising funding for transdermal drug delivery research to drive market
    • TABLE 71 CANADA: MACROECONOMIC INDICATORS
    • TABLE 72 CANADA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 73 CANADA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 74 CANADA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 75 CANADA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 76 CANADA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 77 CANADA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 78 CANADA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 IMPACT OF RECESSION ON EUROPEAN TRANSDERMAL PATCHES MARKET
    • TABLE 79 EUROPE: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 80 EUROPE: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 81 EUROPE: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 82 EUROPE: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 83 EUROPE: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 84 EUROPE: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 85 EUROPE: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 86 EUROPE: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Favorable government policies to aid market growth
    • TABLE 87 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 88 GERMANY: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 89 GERMANY: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 90 GERMANY: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 91 GERMANY: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 92 GERMANY: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 93 GERMANY: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 94 GERMANY: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Increasing funding for R&D of innovative transdermal technologies to drive market
    • TABLE 95 UK: MACROECONOMIC INDICATORS
    • TABLE 96 UK: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 97 UK: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 98 UK: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 99 UK: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 100 UK: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 101 UK: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 102 UK: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.3.4 FRANCE
      • 11.3.4.1 Development of transdermal drug delivery systems by local players to support market growth
    • TABLE 103 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 104 FRANCE: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 105 FRANCE: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 106 FRANCE: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 107 FRANCE: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 108 FRANCE: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 109 FRANCE: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 110 FRANCE: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 High burden of lung cancer to propel market
    • TABLE 111 ITALY: MACROECONOMIC INDICATORS
    • TABLE 112 ITALY: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 113 ITALY: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 114 ITALY: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 115 ITALY: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 116 ITALY: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 117 ITALY: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 118 ITALY: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Growing demand for self-care and personalized medicine to drive market
    • TABLE 119 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 120 SPAIN: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 121 SPAIN: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 122 SPAIN: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 123 SPAIN: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 124 SPAIN: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 125 SPAIN: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 126 SPAIN: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 127 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 128 REST OF EUROPE: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 129 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 130 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 131 REST OF EUROPE: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 132 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL 2021-2029 (USD MILLION)
    • TABLE 133 REST OF EUROPE: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 IMPACT OF RECESSION ON ASIA PACIFIC TRANSDERMAL PATCHES MARKET
    • FIGURE 37 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET SNAPSHOT
    • TABLE 134 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Large diabetic population to drive market
    • TABLE 142 CHINA: MACROECONOMIC INDICATORS
    • TABLE 143 CHINA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 144 CHINA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 145 CHINA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 146 CHINA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 147 CHINA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 148 CHINA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 149 CHINA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.4.3 JAPAN
      • 11.4.3.1 Increasing number of product approvals and growing focus of local players on R&D of transdermal systems to support market growth
    • TABLE 150 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 151 JAPAN: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 152 JAPAN: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 153 JAPAN: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 154 JAPAN: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 155 JAPAN: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 156 JAPAN: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 157 JAPAN: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Increasing focus on noninvasive methods of drug delivery to drive market
    • TABLE 158 INDIA: MACROECONOMIC INDICATORS
    • TABLE 159 INDIA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 160 INDIA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 161 INDIA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 162 INDIA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 163 INDIA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 164 INDIA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 165 INDIA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Rising healthcare spending and increasing government initiatives to propel market
    • TABLE 166 SOUTH KOREA: MACROECONOMIC INDICATORS
    • TABLE 167 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 168 SOUTH KOREA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 169 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 170 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 171 SOUTH KOREA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 172 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 173 SOUTH KOREA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.4.6 AUSTRALIA
      • 11.4.6.1 Increasing number of smokers to drive market
    • TABLE 174 AUSTRALIA: MACROECONOMIC INDICATORS
    • TABLE 175 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 176 AUSTRALIA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 177 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 178 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 179 AUSTRALIA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 180 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 181 AUSTRALIA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 182 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 183 REST OF ASIA PACIFIC: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 184 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 185 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 186 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 187 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 188 REST OF ASIA PACIFIC: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 IMPACT OF RECESSION ON TRANSDERMAL PATCHES MARKET IN LATIN AMERICA
    • TABLE 189 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 190 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 191 LATIN AMERICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 192 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 193 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 194 LATIN AMERICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 195 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 196 LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.5.2 BRAZIL
      • 11.5.2.1 High prevalence of diabetes to propel market
    • TABLE 197 BRAZIL: KEY MACROINDICATORS
    • TABLE 198 BRAZIL: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 199 BRAZIL: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 200 BRAZIL: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 201 BRAZIL: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 202 BRAZIL: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 203 BRAZIL: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 204 BRAZIL: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.5.3 MEXICO
      • 11.5.3.1 Government investments to drive transdermal drug delivery production
    • TABLE 205 MEXICO: KEY MACROINDICATORS
    • TABLE 206 MEXICO: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 207 MEXICO: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 208 MEXICO: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 209 MEXICO: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 210 MEXICO: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 211 MEXICO: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 212 MEXICO: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
    • 11.5.4 REST OF LATIN AMERICA
    • TABLE 213 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 214 REST OF LATIN AMERICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 215 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 216 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 217 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 218 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 219 REST OF LATIN AMERICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 GOVERNMENT SUPPORT TO BOOST LOCAL PRODUCTION TO OFFER GROWTH OPPORTUNITIES FOR TRANSDERMAL PATCH MANUFACTURERS
    • 11.6.2 IMPACT OF RECESSION ON TRANSDERMAL PATCHES MARKET IN MIDDLE EAST AND AFRICA
    • TABLE 220 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY PATCH TYPE, 2021-2029 (USD MILLION)
    • TABLE 221 MIDDLE EAST & AFRICA: DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 222 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY ADHESIVE TYPE, 2021-2029 (USD MILLION)
    • TABLE 223 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 224 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET FOR HORMONE REPLACEMENT THERAPY, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 225 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
    • TABLE 226 MIDDLE EAST & AFRICA: TRANSDERMAL PATCHES MARKET, BY END USER, 2021-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
    • TABLE 227 KEY DEVELOPMENTS IN TRANSDERMAL PATCHES MARKET (JANUARY 2020-OCTOBER 2023)
  • 12.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS
    • FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN TRANSDERMAL PATCHES MARKET
  • 12.3 MARKET SHARE ANALYSIS
    • FIGURE 39 TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2022
  • 12.4 COMPANY FOOTPRINT
    • 12.4.1 FOOTPRINT OF COMPANIES IN TRANSDERMAL PATCHES MARKET
    • 12.4.2 PATCH TYPE FOOTPRINT
    • 12.4.3 ADHESIVE TYPE FOOTPRINT
    • 12.4.4 APPLICATION FOOTPRINT
    • 12.4.5 DISTRIBUTION CHANNEL FOOTPRINT
    • 12.4.6 END-USER FOOTPRINT
    • 12.4.7 REGIONAL FOOTPRINT
  • 12.5 TRANSDERMAL PATCHES MARKET: R&D EXPENDITURE
    • FIGURE 40 R&D EXPENDITURE OF KEY PLAYERS IN TRANSDERMAL PATCHES MARKET (2021 VS. 2022)
  • 12.6 COMPANY EVALUATION MATRIX
    • 12.6.1 STARS
    • 12.6.2 EMERGING LEADERS
    • 12.6.3 PERVASIVE PLAYERS
    • 12.6.4 PARTICIPANTS
    • FIGURE 41 TRANSDERMAL PATCHES MARKET: COMPANY EVALUATION MATRIX, 2022
  • 12.7 SME/STARTUP EVALUATION MATRIX
    • 12.7.1 PROGRESSIVE COMPANIES
    • 12.7.2 STARTING BLOCKS
    • 12.7.3 RESPONSIVE COMPANIES
    • 12.7.4 DYNAMIC COMPANIES
    • FIGURE 42 TRANSDERMAL PATCHES MARKET: SME/STARTUP EVALUATION MATRIX
    • 12.7.5 COMPETITIVE BENCHMARKING
    • TABLE 228 TRANSDERMAL PATCHES MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • 12.8 COMPETITIVE SITUATION AND TRENDS
    • 12.8.1 PRODUCT LAUNCHES
    • TABLE 229 TRANSDERMAL PATCHES MARKET: PRODUCT LAUNCHES, JANUARY 2020-OCTOBER 2023
    • 12.8.2 DEALS
    • TABLE 230 TRANSDERMAL PATCHES MARKET: DEALS, JANUARY 2020-OCTOBER 2023
    • 12.8.3 OTHER DEVELOPMENTS
    • TABLE 231 TRANSDERMAL PATCHES MARKET: OTHER DEVELOPMENTS, JANUARY 2020-OCTOBER 2023

13 COMPANY PROFILES

  • (Business overview, Products offered, Recent developments & MnM View)**
  • 13.1 KEY PLAYERS
    • 13.1.1 HISAMITSU PHARMACEUTICAL CO., INC.
    • TABLE 232 HISAMITSU PHARMACEUTICAL CO., INC.: BUSINESS OVERVIEW
    • FIGURE 43 HISAMITSU PHARMACEUTICAL CO., INC.: COMPANY SNAPSHOT (2022)
    • 13.1.2 VIATRIS INC.
    • TABLE 233 VIATRIS INC.: BUSINESS OVERVIEW
    • FIGURE 44 VIATRIS INC.: COMPANY SNAPSHOT (2022)
    • 13.1.3 NOVARTIS AG
    • TABLE 234 NOVARTIS AG: BUSINESS OVERVIEW
    • FIGURE 45 NOVARTIS AG: COMPANY SNAPSHOT (2022)
    • 13.1.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • TABLE 235 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: BUSINESS OVERVIEW
    • FIGURE 46 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2022)
    • 13.1.5 JOHNSON & JOHNSON
    • TABLE 236 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 47 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
    • 13.1.6 UCB S.A.
    • TABLE 237 UCB S.A.: BUSINESS OVERVIEW
    • FIGURE 48 UCB S.A.: COMPANY SNAPSHOT (2022)
    • 13.1.7 ENDO INTERNATIONAL PLC
    • TABLE 238 ENDO INTERNATIONAL PLC: BUSINESS OVERVIEW
    • FIGURE 49 ENDO INTERNATIONAL PLC: COMPANY SNAPSHOT (2022)
    • 13.1.8 LUYE PHARMA GROUP
    • TABLE 239 LUYE PHARMA GROUP: BUSINESS OVERVIEW
    • FIGURE 50 LUYE PHARMA GROUP: COMPANY SNAPSHOT (2022)
    • 13.1.9 ABBVIE INC.
    • TABLE 240 ABBVIE INC.: BUSINESS OVERVIEW
    • FIGURE 51 ABBVIE INC.: COMPANY SNAPSHOT (2022)
    • 13.1.10 NITTO DENKO CORPORATION
    • TABLE 241 NITTO DENKO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 52 NITTO DENKO CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.11 CIPLA INC.
    • TABLE 242 CIPLA INC.: BUSINESS OVERVIEW
    • FIGURE 53 CIPLA INC.: COMPANY SNAPSHOT (2022)
    • 13.1.12 TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • TABLE 243 TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS OVERVIEW
    • FIGURE 54 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.13 AGILE THERAPEUTICS
    • TABLE 244 AGILE THERAPEUTICS: BUSINESS OVERVIEW
    • FIGURE 55 AGILE THERAPEUTICS: COMPANY SNAPSHOT (2022)
    • 13.1.14 BAYER AG
    • TABLE 245 BAYER AG: BUSINESS OVERVIEW
    • FIGURE 56 BAYER AG: COMPANY SNAPSHOT (2022)
    • 13.1.15 AMNEAL PHARMACEUTICALS LLC
    • TABLE 246 AMNEAL PHARMACEUTICALS LLC: BUSINESS OVERVIEW
    • FIGURE 57 AMNEAL PHARMACEUTICALS LLC: COMPANY SNAPSHOT (2022)
    • 13.1.16 HIKMA PHARMACEUTICALS PLC
    • TABLE 247 HIKMA PHARMACEUTICALS PLC: BUSINESS OVERVIEW
    • FIGURE 58 HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2022)
  • *Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
  • 13.2 OTHER PLAYERS
    • 13.2.1 ALVOGEN GROUP INC.
    • TABLE 248 ALVOGEN GROUP INC.: COMPANY OVERVIEW
    • 13.2.2 SPARSHA PHARMA INTERNATIONAL PVT. LTD.
    • TABLE 249 SPARSHA PHARMA INTERNATIONAL PVT. LTD.: COMPANY OVERVIEW
    • 13.2.3 IONTOPATCH
    • TABLE 250 IONTOPATCH: COMPANY OVERVIEW
    • 13.2.4 MEDHERANT LIMITED
    • TABLE 251 MEDHERANT LIMITED: COMPANY OVERVIEW
    • 13.2.5 ADHEXPHARMA
    • TABLE 252 ADHEXPHARMA: COMPANY OVERVIEW
    • 13.2.6 EVERNOW
    • TABLE 253 EVERNOW: COMPANY OVERVIEW
    • 13.2.7 LEAD CHEMICAL CO., LTD.
    • TABLE 254 LEAD CHEMICAL CO., LTD.: COMPANY OVERVIEW
    • 13.2.8 PURDUE PHARMA L.P.
    • TABLE 255 PURDUE PHARMA L.P.: COMPANY OVERVIEW
    • 13.2.9 MUNDIPHARMA INTERNATIONAL
    • TABLE 256 MUNDIPHARMA INTERNATIONAL: COMPANY OVERVIEW
  • 13.3 COMPANIES PROVIDING ADHESIVES FOR TRANSDERMAL PATCHES
    • 13.3.1 WACKER CHEMIE AG
      • 13.3.1.1 Business overview
    • TABLE 257 WACKER CHEMIE AG: BUSINESS OVERVIEW
    • FIGURE 59 WACKER CHEMIE AG: COMPANY SNAPSHOT (2022)
      • 13.3.1.2 Products offered
    • 13.3.2 ELKEM ASA
      • 13.3.2.1 Business overview
    • TABLE 258 ELKEM ASA: BUSINESS OVERVIEW
    • FIGURE 60 ELKEM ASA: COMPANY SNAPSHOT (2022)
      • 13.3.2.2 Products offered
    • 13.3.3 DUPONT DE NEMOURS, INC.
      • 13.3.3.1 Business overview
    • TABLE 259 DUPONT DE NEMOURS, INC.: BUSINESS OVERVIEW
    • FIGURE 61 DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT (2022)
      • 13.3.3.2 Products offered
    • 13.3.4 KATECHO, LLC
    • TABLE 260 KATECHO, LLC: COMPANY OVERVIEW
    • 13.3.5 POLYMER SCIENCE, INC.
    • TABLE 261 POLYMER SCIENCE, INC.: COMPANY OVERVIEW

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS